Classification of Childhood White Matter Disorders Using Proton MR Spectroscopic Imaging

References

1. ↵
   Aubourg P. The leukodystrophies: a window to myelin. Nat Genet 1993;5:105–06

   CrossRefPubMed
2. Barkovich A, Lyon G, Ezrard P. Formation, maturation, and disorders of white matter. AJNR Am J Neuroradiol 992;13:447–61
3. ↵
   van der Knaap MS, Valk J. Magnetic Resonance Myelination and Myelin Disorders. Berlin, Germany: Springer-Verlag;2005
4. ↵
   van der Knaap M, Breiter S, Naidu S. Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology 1999;213:121–33

   CrossRefPubMedWeb of Science
5. ↵
   Moroni I, Bugiani M, Bizzi A, et al. Cerebral white matter involvement in children with mitochondrial encephalopathies. Neuropediatrics 2002;33:79–85

   CrossRefPubMedWeb of Science
6. ↵
   Barker PB, Horska A. Neuroimaging in leukodystrophies. J Child Neurol 2004;19:559–70

   Abstract/FREE Full Text
7. ↵
   Duyn JH, Gillen J, Sobering G, et al. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993;188:277–82

   PubMedWeb of Science
8. ↵
   Golay X, Gillen J, van Zijl PC, et al. Scan time reduction in proton magnetic resonance spectroscopic imaging of the human brain. Magn Reson Med 2002;47:384–87

   CrossRefPubMed
9. ↵
   Bizzi A, Bugiani M, Danesi U. MR spectroscopy of inborn errors of metabolism. In: Gillard JH, Waldman AD, Barker PB, eds. Clinical MR Neuroimaging Diffusion, Perfusion and Spectroscopy. Cambridge, UK: Cambridge University Press;2005 :779–802
10. ↵
    Bizzi A, Danesi U. Proton MR spectroscopy as a diagnostic tool in leukoencephalopathies. In: Uziel G, Taroni F, eds. Hereditary Leukoencephalopathies and Demyelinating Neuropathies in Children. Montrouge, France: John Libbey Eurotext;2004;65–78
11. ↵
    Soher B, van Zijl P, Duyn J, et al. Quantitative proton spectroscopic imaging of the human brain. Magn Reson Med 1996;35:356–63

    PubMedWeb of Science
12. ↵
    Matalon R, Michals K, Sebesta D, et al. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet 1988;29:463–71

    CrossRefPubMedWeb of Science
13. ↵
    Horska A, Kaufmann WE, Brant LJ, et al. In vivo quantitative proton MRSI study of brain development from childhood to adolescence. J Magn Reson Imaging 2002;15:137–43

    CrossRefPubMedWeb of Science
14. ↵
    Kruse B, Barker PB, van Zijl PC, et al. Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy. Ann Neurol 1994;36:595–608

    CrossRefPubMedWeb of Science
15. ↵
    Eichler FS, Itoh R, Barker PB, et al. Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology 2002;225:245–52

    PubMedWeb of Science
16. ↵
    Davie CA, Hawkins CP, Barker GJ, et al. Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet 1993;341:630–31

    PubMedWeb of Science
17. ↵
    van der Voorn JP, Pouwels PJ, Hart AA, et al. Childhood white matter disorders: quantitative MR imaging and spectroscopy. Radiology 2006;241:510–17

    CrossRefPubMedWeb of Science